Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Markers that can Reflect Asthmatic Activity before and after Reduction of Inhaled Corticosteroids: A Pilot Study.

Kato G, Takahashi K, Izuhara K, Komiya K, Kimura S, Hayashi S.

Biomark Insights. 2013 Aug 4;8:97-105. doi: 10.4137/BMI.S12537. eCollection 2013.

2.

Inflammatory markers and acid-base equilibrium in exhaled breath condensate of stable and unstable asthma patients.

Tomasiak-Lozowska MM, Zietkowski Z, Przeslaw K, Tomasiak M, Skiepko R, Bodzenta-Lukaszyk A.

Int Arch Allergy Immunol. 2012;159(2):121-9. doi: 10.1159/000335674. Epub 2012 May 30.

3.

Increased periostin associates with greater airflow limitation in patients receiving inhaled corticosteroids.

Kanemitsu Y, Matsumoto H, Izuhara K, Tohda Y, Kita H, Horiguchi T, Kuwabara K, Tomii K, Otsuka K, Fujimura M, Ohkura N, Tomita K, Yokoyama A, Ohnishi H, Nakano Y, Oguma T, Hozawa S, Nagasaki T, Ito I, Oguma T, Inoue H, Tajiri T, Iwata T, Izuhara Y, Ono J, Ohta S, Tamari M, Hirota T, Yokoyama T, Niimi A, Mishima M.

J Allergy Clin Immunol. 2013 Aug;132(2):305-12.e3. doi: 10.1016/j.jaci.2013.04.050. Epub 2013 Jun 19.

4.

Leukotrienes and 8-isoprostane in exhaled breath condensate of children with stable and unstable asthma.

Zanconato S, Carraro S, Corradi M, Alinovi R, Pasquale MF, Piacentini G, Zacchello F, Baraldi E.

J Allergy Clin Immunol. 2004 Feb;113(2):257-63. Erratum in: J Allergy Clin Immunol. 2004 Apr;113(4):676.

PMID:
14767439
5.

High-sensitivity C-reactive protein in the exhaled breath condensate and serum in stable and unstable asthma.

Zietkowski Z, Tomasiak-Lozowska MM, Skiepko R, Mroczko B, Szmitkowski M, Bodzenta-Lukaszyk A.

Respir Med. 2009 Mar;103(3):379-85. doi: 10.1016/j.rmed.2008.10.003. Epub 2008 Nov 17.

6.

Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients.

Jia G, Erickson RW, Choy DF, Mosesova S, Wu LC, Solberg OD, Shikotra A, Carter R, Audusseau S, Hamid Q, Bradding P, Fahy JV, Woodruff PG, Harris JM, Arron JR; Bronchoscopic Exploratory Research Study of Biomarkers in Corticosteroid-refractory Asthma (BOBCAT) Study Group.

J Allergy Clin Immunol. 2012 Sep;130(3):647-654.e10. doi: 10.1016/j.jaci.2012.06.025. Epub 2012 Aug 1.

7.

Asthma control test (ACT): comparison with clinical, functional, and biological markers of asthma control.

Melosini L, Dente FL, Bacci E, Bartoli ML, Cianchetti S, Costa F, Di Franco A, Malagrinò L, Novelli F, Vagaggini B, Paggiaro P.

J Asthma. 2012 Apr;49(3):317-23. doi: 10.3109/02770903.2012.661008. Epub 2012 Mar 9.

PMID:
22401649
8.

The inflammatory marker serum eosinophil cationic protein (ECP) compared with PEF as a tool to decide inhaled corticosteroid dose in asthmatic patients.

Löwhagen O, Wever AM, Lusuardi M, Moscato G, De Backer WA, Gandola L, Donner CF, Ahlstedt S, Larsson L, Holgate ST.

Respir Med. 2002 Feb;96(2):95-101.

PMID:
11862965
9.

Eotaxin-1 in exhaled breath condensate of stable and unstable asthma patients.

Zietkowski Z, Tomasiak-Lozowska MM, Skiepko R, Zietkowska E, Bodzenta-Lukaszyk A.

Respir Res. 2010 Aug 12;11:110. doi: 10.1186/1465-9921-11-110.

10.
11.

Dose-ranging study of lebrikizumab in asthmatic patients not receiving inhaled steroids.

Noonan M, Korenblat P, Mosesova S, Scheerens H, Arron JR, Zheng Y, Putnam WS, Parsey MV, Bohen SP, Matthews JG.

J Allergy Clin Immunol. 2013 Sep;132(3):567-574.e12. doi: 10.1016/j.jaci.2013.03.051. Epub 2013 May 29.

PMID:
23726041
12.

[Sensitivity of sputum eosinophil cationic protein level for monitoring asthmatic patients with normal peak expiratory flow].

Nakazawa T, Kagami M, Matumura R, Kawashima T, Matuzuwa Y, Takada M.

Arerugi. 1999 Oct;48(10):1153-60. Japanese.

PMID:
10554401
13.

Effect of treatment with inhaled corticosteroid on serum periostin levels in asthma.

Hoshino M, Ohtawa J, Akitsu K.

Respirology. 2016 Feb;21(2):297-303. doi: 10.1111/resp.12687. Epub 2015 Nov 26.

14.

Exogenous stimuli and circadian peak expiratory flow variation in allergic asthmatic children.

Meijer GG, Postma DS, van der Heide S, de Reus DM, Roorda RJ, Koëter GH, van Aalderen WM.

Am J Respir Crit Care Med. 1996 Jan;153(1):237-42.

PMID:
8542122
15.

RANTES in exhaled breath condensate of stable and unstable asthma patients.

Zietkowski Z, Tomasiak MM, Skiepko R, Bodzenta-Lukaszyk A.

Respir Med. 2008 Aug;102(8):1198-202. doi: 10.1016/j.rmed.2008.03.010. Epub 2008 Jul 7.

16.

Periostin in Exhaled Breath Condensate and in Serum of Asthmatic Patients: Relationship to Upper and Lower Airway Disease.

Wardzyńska A, Makowska JS, Pawełczyk M, Piechota-Polańczyk A, Kurowski M, Kowalski ML.

Allergy Asthma Immunol Res. 2017 Mar;9(2):126-132. doi: 10.4168/aair.2017.9.2.126.

17.

The efficacy of single-high dose inhaled corticosteroid versus oral prednisone treatment on exhaled leukotriene and 8-isoprostane levels in mild to moderate asthmatic children with asthma exacerbation.

Keskin O, Uluca U, Keskin M, Gogebakan B, Kucukosmanoglu E, Ozkars MY, Kul S, Bayram H, Coskun Y.

Allergol Immunopathol (Madr). 2016 Mar-Apr;44(2):138-48. doi: 10.1016/j.aller.2015.05.006. Epub 2015 Aug 28.

PMID:
26318413
18.

Exhaled breath condensate cytokines and pH in pediatric asthma and atopic dermatitis.

Brunetti L, Francavilla R, Tesse R, Fiermonte P, Fiore FP, Loré M, Margiotta M, Armenio L.

Allergy Asthma Proc. 2008 Sep-Oct;29(5):461-7. doi: 10.2500/aap.2008.29.3152.

PMID:
18926054
20.

[Eosinophil count in induced sputum samples as a marker of airway inflammation and adequacy of corticosteroid inhalation treatment in asthmatic patients].

Tomii K, Matsumura Y, Taguchi Y, Oida K, Kobash Y.

Nihon Kokyuki Gakkai Zasshi. 1998 Feb;36(2):138-43. Japanese.

PMID:
9617140

Supplemental Content

Support Center